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Long-lived monocytes, macrophages, and dendritic
cells (DCs) are Toll-like receptor-expressing, antigen-
presenting cells derived from a common myeloid lin-
eage that play key roles in innate and adaptive im-
mune responses. Based on immunohistochemical and
molecular analyses of inflamed tissues from patients
with chronic destructive periodontal disease, these
cells, found in the inflammatory infiltrate, may drive
the progressive periodontal pathogenesis. To investi-
gate early transcriptional signatures and subsequent
proteomic responses to the periodontal pathogen, Por-
phyromonas gingivalis, donor-matched human blood
monocytes, differentiated DCs, and macrophages were
exposed to P. gingivalis lipopolysaccharide (LPS) and
gene expression levels were measured by oligonucleo-
tide microarrays. In addition to striking differences in
constitutive transcriptional profiles between these my-
eloid populations, we identify a P. gingivalis LPS-induc-
ible convergent, transcriptional core response of more
than 400 annotated genes/ESTs among these popula-
tions, reflected by a shared, but quantitatively distinct,
proteomic response. Nonetheless, clear differences
emerged between the monocytes, DCs, and macro-
phages. The finding that long-lived myeloid inflam-
matory cells, particularly DCs, rapidly and aggres-
sively respond to P. gingivalis LPS by generating
chemokines, proteases, and cytokines capable of
driving T-helper cell lineage polarization without ev-
idence of corresponding immunosuppressive path-
ways highlights their prominent role in host defense
and progressive tissue pathogenesis. The shared,
unique, and/or complementary transcriptional and
proteomic profiles may frame the context of the host
response to P. gingivalis , contributing to the destruc-
tive nature of periodontal inflammation. (Am J Pathol
2009, 174:1400–1414; DOI: 10.2353/ajpath.2009.080677)
Innate and adaptive host defense mechanisms develop
to counter infection and spread of bacterial, viral, and fungal
organisms. In innate immunity, recognition of highly con-
served pathogen-associated molecular patterns (PAMPs)
by transmembrane host pattern-recognition receptors such
as Toll-like receptors (TLRs) and cytoplasmic sensors in-
cluding nucleotide-oligomerization domain (Nod)-like re-
ceptors initiate signaling cascades driving antimicrobial
host defense.1,2 PAMPs like lipopolysaccharide (LPS), a
structural component of Gram-negative bacterial cell walls,
form a LPS-TLR complex leading to activation of transcrip-
tional programs including nuclear factor (NF)-B- and Jun/
Fos-targeted expression of inflammatory mediators critical
in host defense and stimulation of adaptive immunity, but in
excess, detrimental to the host.
In the oral cavity, immune-mediated destruction of the
supporting tissues surrounding the dentition is a character-
istic feature of chronic inflammatory periodontal disease,3,4
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one of the most prevalent of infectious diseases. The infectious
component central to the etiology of periodontal disease en-
tails colonization of the oral niche with Gram-negative bacteria,
including Porphyromonas gingivalis, a nonspore forming, non-
motile, obligate anaerobe strongly implicated in the patho-
genic sequelae.5 Elevated levels of P. gingivalis are present in
periodontal lesions and are significantly reduced by success-
ful therapy.6 Primarily considered an oral pathogen, a signifi-
cant body of emerging evidence now supports an association
with systemic conditions such as coronary artery disease,
diabetes, stroke, and preterm birth.7
P. gingivalis features numerous intensely studied struc-
tural and secreted components capable of interacting
with the host immune system. Among its virulence fac-
tors, fimbrial proteins bind to and trigger epithelial TLR2,8
whereas P. gingivalis LPS activates TLR2- and/or TLR4-
expressing cells.9–13 As a result of its unique structural and
chemical properties, P. gingivalis LPS exhibits lower levels of
endotoxic potency compared with classic enterobacterial
preparations such as Escherichia coli LPS, perhaps because
of lower binding affinity to host LPS-binding protein as well
as its dual recognition by TLR2 and TLR4.14
An additional possibility is that P. gingivalis LPS may
interact with different cell populations to orchestrate a
smoldering inflammatory response. Beyond the initial en-
counter with TLR2 epithelial cells, P. gingivalis and its
LPS may differentially trigger TLR2 and TLR4 cells
within the context of inflamed oral mucosa to secrete
inflammatory molecules, which underlie ensuing P. gingi-
valis-driven pathogenesis. Among these targeted popu-
lations are innate immune cells of myeloid origin, includ-
ing recruited peripheral blood monocytes, immature and
mature DCs, and differentiated macrophages, yet little is
known of their differential responses to inflammatory stim-
uli, such as P. gingivalis. Prior studies have examined P.
gingivalis stimulation of primary human monocyte or mac-
rophage populations,15 but this has not been examined in
these populations relative to one another, nor linked with the
central innate immune population of myeloid DCs. Given the
common lineage of these myeloid populations and their
seminal, but discrete roles in innate and adaptive immunity,
we explored their shared and/or differential responses to P.
gingivalis LPS as a means to understand their respective
contributions in systemic and locally mediated diseases
and in guiding T-helper cell recruitment and lineage bias.
Importantly, both convergent and divergent transcriptional
and proteomic profiles to P. gingivalis LPS were identified as
a basis to begin unraveling the complex inflammatory re-
sponse to microbial challenge and to identify potential tar-
gets in interrupting the chronic destructive nature of peri-
odontal disease and/or its systemic manifestations.
Materials and Methods
Patient Selection, Tissue Collection,
and Transcriptional Profile Analysis
Periodontal tissues were harvested from systemically
healthy adult patients undergoing routine oral surgery
procedures, after informed consent (institutional review
board, OSR58034, Loma Linda University School of Den-
tistry). Diseased tissue samples were harvested from
chronic periodontitis patients, diagnosed according to the
latest American Academy of Periodontology criteria.16 In-
clusion criteria for diseased tissues were evidence of in-
flammation (bleeding on probing) and loss of tooth-support-
ing structures (clinical attachment loss 4 mm and
radiographical bone loss).16 Healthy tissue samples dis-
played no visible inflammation or loss of attachment and
were collected during cosmetic oral surgery procedures. All
tissues were bisected and processed for histology or isola-
tion of RNA using TRIzol reagent (Invitrogen, Carlsbad, CA).
Immunohistochemistry
Gingival samples were fixed in 10% neutral-buffered for-
malin and embedded in paraffin. Serial 5- to 7-m sec-
tions were stained with hematoxylin and eosin (H&E) for
histopathology or incubated with monoclonal antibodies
to CD68 (monocyte/macrophage; DAKO, Carpinteria,
CA), CD1a (DCs) and CD3 (T cells) (Abcam, Cambridge,
MA), interleukin (IL)-17 (Santa Cruz Biotechnology, Santa
Cruz, CA), interferon (IFN)-, IL-4 (Abcam, Cambridge,
MA) or an irrelevant isotype as described.17
Myeloid Cell Preparation and Stimulation
Human peripheral blood mononuclear cells obtained
from healthy volunteers at the Department of Transfusion
Medicine (National Institutes of Health, Bethesda, MD)
were diluted in endotoxin-free phosphate-buffered saline
(PBS) without Ca2 and Mg2 (BioWhittaker, Walkers-
ville, MD) and density-sedimented on lymphocyte sepa-
ration medium (ICN Pharmaceuticals, Aurora, OH).
Monocytes were purified from the mononuclear cell layer
using centrifugal elutriation18 and divided into three
groups for immature monocytes and generation of mac-
rophages and DCs as described19,20 in three indepen-
dent experiments with cells from three donors. Freshly
isolated monocytes were used immediately after elutria-
tion, whereas donor-matched macrophage and DC stud-
ies were initiated after confirmation of differentiation on
day 7. The viability of each cell type was 95% as mea-
sured by trypan blue exclusion and phenotype was con-
firmed with the following fluorochrome-conjugated antibod-
ies: CD14, HLA-DR, DC-SIGN, CD3, CD19, CD1a, CD68,
TLR2, and TLR4 (Becton Dickinson, Sunnyvale, CA), be-
fore stimulation as measured by flow cytometry (FACS-
Calibur, Becton Dickinson). Cell aliquots were left un-
treated (medium control) or stimulated with 100 ng/ml of
P. gingivalis LPS (American Type Culture Collection no.
33277, generous gift from Richard Darveau, University of
Washington, Seattle, WA)9 which contained 0.1% pro-
tein contamination9 for 1 hour or stimulated in parallel with
100 ng/ml of E. coli LPS (055:B5; Sigma, St. Louis, MO).
Additional cultures were exposed to intact P. gingivalis at cell
to bacteria ratios of 1:10 and 1:5 for 30 minutes and pro-
cessed for total RNA or protein. In separate studies, P.
gingivalis bacteria were washed in PBS, incubated in fluo-
rescein isothiocyanate (100 g/ml for 30 minutes),21 and
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washed in cell culture media before being added to macro-
phage monolayers for indicated times at room temperature.
The cultures were examined for bacterial binding using a Zeiss
fluorescence microscope (Carl Zeiss, Thornwood, NY).
Myeloid Cell Transcriptional Profile Analysis
The cells were lysed and total RNA isolated using TRIzol
reagent and further purification was performed using
RNeasy mini columns (Qiagen, Valencia, CA) followed by
assessment of RNA integrity using the 2100 Bioanalyzer
(Agilent, Foster City, CA). Preparation of biotin-labeled
cRNA, hybridization, and scanning were performed ac-
cording to protocol (Affymetrix, Santa Clara, CA) as de-
scribed.19 Affymetrix GCOS version 1.2 software was
used to calculate signal and present call values that were
stored in the NIHLIMS, a database for storage and re-
trieval of chip data maintained at the National Institutes of
Health. The signal values for the 18 chips were subjected
to S10 quantile-normalizing transformation.19 Principal
components analysis on the S10-transformed data were
also performed to permit the visualization of the samples
in bivariate plots of the low-order principal components,
to detect possible outliers and to provide a global view of
the study results. Statistical tests and data calculations
were with MSCL Analyst’s Toolbox (http://abs.cit.nih.gov/
main/geneexpression.html).
A three-level, one-way blocked analysis of variance
compared the baseline expression levels of monocytes
(MON control), dendritic cells (DC control), and macro-
phages (MAC control). Probesets, which manifest signif-
icant (FDR, 10%), very substantial (30-fold) differ-
ences among these unstimulated groups, and were
called present, were collected. This collection was hier-
archically clustered according to relative expression level
among the three cell types. Next, after exposure to P.
gingivalis LPS, probesets showing a significant (based on
one-way, six-level blocked analysis of variance; FDR,
10%), substantial (more than threefold) change in ex-
pression level in any one of the cell types were collected
into a second group. Although the majority of these
probesets showed a similar profile of behavior over all
three cell types, increasing or more rarely, decreasing
expression with P. gingivalis LPS exposure, some probe-
sets showed changes to a greater or lesser degree in
DCs or MAC than in MON. Probesets with differential
expression (more than twofold) in monocytes and more
than threefold more differential expression in the other
cells, were separately identified. Conversely, probesets
showing more than twofold differential in DCs or MAC, yet
more than threefold greater differential expression in
MON were also collected. These probesets distinguished
the response profiles for each cell type.
Real-Time Polymerase Chain Reaction (PCR)
Total RNA (1 g) from each sample was reverse-tran-
scribed using an oligodeoxythymidylic acid primer (In-
vitrogen) and the resulting cDNA amplified by real-time
PCR on an ABI Prism 7500 sequence detector (Applied
Biosystems, Foster City, CA). Amplification was performed
with TaqMan expression assays for HPRT (assay ID:
Hs9999909_m1), -actin (assay ID: Hs9999903_m1), tumor
necrosis factor (TNF)- (assay ID: Hs00174128_m1), CCL3
(assay ID: Hs00234142_m1), and SOCS4 (assay ID:
Hs00377781_m1) from Applied Biosystems. HPRT and
-actin housekeeping genes were used for normalization
controls. Amplification parameters and conditions were set
by the manufacturer. Data were analyzed using the 2CT
method22 and results were reported as fold change.
Protein Expression Profiling
Eight independent experiments were performed with
cells derived from eight healthy donors. Myeloid cell pop-
ulations were cultured and stimulated as described
above. After 24 hours with or without P. gingivalis LPS or E.
coli LPS, the media were collected, spun at 12,000  g,
transferred to fresh tubes, and stored at 70°C. Super-
natants were diluted fourfold in assay diluent (BioSource
International, Camarillo, CA) before analysis using the
Human Cytokine 25-Plex kit (Biosource, Invitrogen) and
the Luminex 100 system (Luminex, Austin, TX). Data are
expressed as mean  SEM, compared using two-tailed
Student’s t-test for correlated samples (http://faculty.
vassar.edu/lowry/VassarStats.html), and results consid-
ered significant at P  0.05.
Results
Gene Expression in Inflamed Oral Mucosa
and Infiltrating Myeloid Cells
In situ analysis of gingival tissues from patients with
chronic periodontitis revealed the presence of large num-
bers of inflammatory cells compared with tissues from
patients with noninflamed gingiva (Figure 1, A and B),
and by preliminary microarray analysis, differential ex-
pression of multiple genes consistent with recruitment
and activation of myeloid cell populations was evident (S.
Nares, et al, manuscript in preparation). On further anal-
ysis of the inflamed tissues by immunohistochemistry,
cells of myeloid lineage, including CD1a-positive den-
dritic cells (DCs) within the epithelium and within regions
populated by inflammatory infiltrates (Figure 1C) and
CD68 monocytes and macrophages (Figure 1, D and E)
were seen. Monocytes were adherent to the endothelium
(Figure 1D) and/or emigrated into the tissues (Figure 1E)
within the inflammatory site. By comparison, healthy hu-
man gingival samples displayed minimal histological ev-
idence of inflammatory infiltrates (Figure 1A), prompting
our subsequent emphasis on the contribution of the my-
eloid cells to the inflammatory and tissue-destructive
events characteristic of periodontal diseases.
Gene Expression in Myeloid Cell Populations
To elucidate the potential role of infiltrating myeloid cells
in the defensive host response to periopathic bacteria
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and its evolution into a chronic destructive process, we
compared the quantitative and qualitative responses of
cells of myeloid lineage to P. gingivalis, considered a
primary etiological agent in the initiation and persistence
of periodontal disease. After isolation of human periph-
eral blood monocytes, the cells were used immediately
as immature circulating monocyte populations or were
differentiated into myeloid DCs and macrophages. We
then compared the responses of the three maturationally
distinct donor-matched populations to identical concentra-
tions of TLR-activating P. gingivalis LPS, as a more uniform
signal than the viable microbes. Demonstration of matura-
tional status by flow cytometry revealed that phenotypically,
monocytes were CD14, HLA-DR, DC-SIGN, CD3, and
CD19, immature DCs were CD1a, HLA-DR, DC-SIGN,
CD86, CD14low/, CD3, CD19, whereas differentiated
macrophages were CD14, HLA-DR, CD68, CD3,
CD19, DC-SIGN (Figure 2, A–C; CD14, CD68, and DC-
SIGN shown).
After exposure to purified P. gingivalis LPS or an equiv-
alent volume of PBS (control, unstimulated) for 1 hour, the
early transcriptional responses of the three donor-
matched cell populations were compared using oligonu-
cleotide arrays. By activating the cells for only 1 hour, we
focused on the primary TLR responses, minimizing down-
stream signaling effects and their potential differential
consequences on gene transcription in each population.
First, however, we noted a remarkable differential consti-
tutive transcriptional profile among the three derivative
populations, not attributable to donor variability. The
unique subsets of genes detected in donor-matched un-
stimulated monocytes, DCs, and macrophages may dis-
tinguish the functional repertoire of these populations in
host defense. To define these gene signatures more spe-
cifically, the most striking (30-fold or greater) differentially
expressed probesets (n  184) were hierarchically clus-
tered (Figure 3, Table 1, and Supplemental Table S1
available at http://ajp.amjpathol.org). The cluster repre-
sented in red highlights those genes constitutively ex-
pressed at higher levels in the DCs 	Figure 3, hierarchical
and parallel plot cluster (n  3 donors); Table 1, top 20
shown
. Notably, DCs independently expressed high lev-
els of CD209 (DC-SIGN) and CD1, consistent with their
phenotype, along with CD23A (IgE receptor), IL-17 re-
ceptor B, and histamine receptor (H1). Baseline en-
zymes, cathepsin C and arachidonate 15-lipoxygenase,
also distinguished these cells from their myeloid counter-
parts. Constitutive expression of a myriad of CC chemo-
kines (CCL8, CCL13, CCL14, CCL17, CCL18, CCL23,
CCL24, CCL26) suggests that this population is at the
ready to drive recruitment of innate effector cells on chal-
lenge with pathogens and antigens.
On the other hand, differentiated macrophages share
a subset of baseline genes with DCs (Figure 3, orange
cluster; and Supplemental Table S1 available at http://
ajp.amjpathol.org): APOE, fibronectin, alpha2 macro-
globulin, mannose receptor, succinate receptor, formyl
peptide receptor-like 2/FPRL2, TREM 2, neuropilin,
C1q, and CCL22), but uniquely (Figure 3, blue cluster;
and Table 1) exhibit a repertoire of enzymes, including
DNase, MMP7, MMP9, decysin, a disintegrin and met-
alloprotease (ADAM) family member linked to monocyte
Figure 1. Histology and immunohistochemistry
of gingival tissues. Biopsy specimens from
healthy (A) and periodontally-involved (B) gin-
gival tissues reveal dense inflammatory infil-
trates in diseased specimens with minimal scat-
tered accumulations of inflammatory cells in
healthy samples (H&E). C: DCs in epithelium
and in inflammatory infiltrates are stained with
CD1a (arrows). D and E: Immunohistochemical
staining of inflamed periodontal tissues with anti-
bodies (CD68) that detect monocytes and macro-
phages (arrows). F: Staining of inflamed tissues
with antibodies to T-cell-specific CD3. G–I: Stain-
ing of inflamed tissues adjacent to epithelium
(right in each panel) with antibodies to IL-17 (G),
IL-4 (H), and IFN- (I). Original magnifications:
10 (A, B); 20 (C, G–I); 40 (D, E); 20 (F).
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differentiation,23 lipases, chitinases with innate anti-fun-
gal activity toward chitin-containing fungi,24 and ATPase
(V0 subunit d2). Immature monocytes, freshly isolated
from peripheral blood, and parental to DCs and macro-
phages, display their own profile of constitutively highly
expressed genes (Figure 3, green cluster; and Table 1).
Among the genes relatively overexpressed in immature
monocytes were genes linked with innate immunity in-
cluding several S100 calcium-binding proteins (S100A8,
S100A9, S100A12), 1 defensin, Fc receptor (CD89),
selectin L, FPR1, and CXCR4. Other genes are distinc-
tively enriched in resting immature monocytes, such as
serpins, cyclin-dependent kinase inhibitor 1C (p57/Kip2),
dual specificity phosphatase (DUSP)6, and properdin.
Versican, a large chondroitin sulfate proteoglycan, asso-
ciated with monocytes in wound healing, tissue remod-
eling, and myocardial infarcts25 was more abundantly
expressed in monocytes.
P. gingivalis-Inducible Gene and Protein
Expression in Myeloid Cells
On exposure to P. gingivalis LPS, however, the three de-
rivative donor-matched populations all responded with
enhanced transcription of a plethora of pro-inflammatory
genes, with 567 probesets showing demonstrable re-
sponses in at least one cell type (Supplemental Table S2
available at http://ajp.amjpathol.org). The use of donor-
matched cells of different maturation levels ensured a
less heterogeneous response to TLR signal-induced
stimulation and in response to P. gingivalis LPS, a striking
pattern of convergent gene expression of the three de-
rivative myeloid populations suggested an early myeloid
inflammatory transcriptional core response to P. gingivalis
LPS. This response was clearly consistent with engage-
ment of the TLR-NF-B signaling network underlying ex-
pression of proinflammatory cytokines, anti-apoptotic
factors, and antimicrobial molecules, crucial to an anti-
microbial response of the host, and reflective of the ability
of the purified preparation of P. gingivalis LPS that is
enriched for two lipid A species (1435/1450) to activate
TLR2, TLR2/1, and TLR4.9
Of the 567 P. gingivalis LPS-inducible probesets, mod-
ulation of molecules linked to intracellular signaling and
regulation of NF-B activity (NF-BIA, NF-BIZ, IRAK2,
RIPK2, NF-B2, EGR1, EGR3, DUSP1, DUSP2) (Supple-
mental Table S2 available at http://ajp.amjpathol.org) was
consistent with TLR activation and induction of NF-B-
responsive genes, including induction of cytokine
genes (IL-1, IL-1, IL-6, TNF-, IFN-1) and chemo-
kines. Reflecting the up-regulation of TNF-, TNF-
inducible genes/proteins were also rapidly up-regu-
lated in cells exposed to P. gingivalis LPS (TNFAIP2,
TNFAIP3, TNFAIP6, TNFAIP8). To corroborate the mi-
croarray expression profiling data, real-time PCR was
performed for several representative genes found to be
significantly influenced in response to P. gingivalis LPS, as
shown for TNF- (Figure 4A). Although the two assays are
numerically not directly comparable, with RT-PCR being
more sensitive, the directional magnitude of the in-
creased expression levels was consistent. Moreover,
when culture protein levels were monitored by multiplex
bead assay, the striking increases in P. gingivalis LPS-
induced TNF- protein verified the gene induction, as
well as the cell-specific responses of TNF- expression
(Figure 4B, log scale).
To demonstrate that intact P. gingivalis microorgan-
isms, in addition to their cell wall-derived components,
also influence these cells to generate the panoply of
pathogenic inflammatory mediators, we exposed adher-
ent monocyte-derived macrophages to viable bacteria.
Addition of fluorescein isothiocyanate-tagged P. gingivalis
to macrophage monolayers resulted in rapid binding to
macrophage membranes (Figure 4C, inset), followed by
Figure 2. Phenotypic analysis of monocytes and
differentiated DCs and macrophages. Freshly
isolated peripheral blood monocytes (A), cul-
tured and differentiated monocyte-derived DCs
(B), and differentiated monocyte-derived macro-
phages (C) as shown in the left panels, were
stained with the following fluorochrome-conju-
gated antibodies: CD14, CD68, and DC-SIGN
and cellular phenotypes determined by flow cy-
tometry analysis, right panels.
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internalization (Figure 4C). Furthermore, this encounter
with intact bacteria resulted in induction of gene expres-
sion in the P. gingivalis-infected macrophages. By RT-
PCR, TLR-dependent signaling resulted in transcriptional
up-regulation of inflammatory cytokines, represented by
TNF- (Figure 4D), subsequent to NF-B activation. Col-
lectively, these data indicate that P. gingivalis and/or its
endotoxin component can interact with myeloid cell pop-
ulations to trigger transcription, production, and secretion
of inflammatory mediators including chemokines, cyto-
kines, and proteases, all of which may be instrumental in
negotiating the path to chronic inflammation and tissue
destruction characteristic of periodontal disease. Thus,
this approach of exploring myeloid cell-induced gene
and protein expression in response to P. gingivalis LPS in
vitro provides reproducible data consistent with the pres-
ence and activation status of innate immune cells in
inflamed gingiva in which P. gingivalis is considered a
pivotal mediator of immunopathology.
Cell-Specific Responses to P. gingivalis LPS
In addition to the distinct differences in baseline/unstimu-
lated transcriptional profiles between monocytes, DCs,
and macrophages, and the core P. gingivalis LPS re-
sponse across these populations, cell-specific gene reg-
ulation was also evident. The most dramatic of these are
presented in Figure 5 in which the P. gingivalis LPS-
induced gene profiles of DCs and macrophages are
plotted against that of monocytes. In Figure 5A, MON P.
gingivalis (Pg)LPS/C is plotted against DC PgLPS/C to
differentiate probesets with more than threefold response
in DCs (44 probesets, above green line) than MON, and
probesets more than threefold in MON compared with
DCs (eight probesets, below red line). A similar compar-
ison between MON and MAC revealed 19 probesets
greater in MAC than MON (Figure 5B, above blue line),
whereas 16 probesets were higher in MON than MAC
(below red line). Although the majority (60%) of the 567
differentially expressed probesets lie within the lines of
identity (less than threefold difference between the two
populations), those differentially expressed may be of
consequence in the acute compared with chronic mi-
lieu of the inflamed gingiva. To further delineate shared
and distinct maturation-dependent responses, a rela-
tive comparison across all three cell types for genes
most differentially expressed at levels more than or
equal to fivefold between at least two of the cell pop-
Figure 3. Hierarchical cluster of differentially expressed genes in three cell types. A: The microarray
data were transformed and normalized using the S10 transform and probesets that are present (50%)
in one of the three groups and differ by greater than 30-fold among cell types were selected.
Expression levels relative to mean for these 184 probesets were clustered according to Ward’s
method. Selected gene symbols are given (full list in Supplemental Table S1 available at http://
ajp.amjpathol.org). B: Parallel line plots of relative expression of each probeset, in separate clusters
reveal distinct patterns of expression in monocytes (MON), dendritic cells (DC), and macrophages
(MAC).
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ulations after P. gingivalis LPS stimulation is summa-
rized in Table 2.
DCs were the most transcriptionally responsive to P.
gingivalis LPS with 434 probesets (Supplemental Table S2
available at http://ajp.amjpathol.org), whereas monocytes
(270 probesets) and macrophages (224 probesets) re-
sponded with a somewhat reduced gene profile. Analysis of
individual cellular responses revealed a number of uniquely
Table 1. Top 20 Constitutively Expressed Genes in Unstimulated Monocytes, Macrophages, and Dendritic Cells*
Monocytes
S100 calcium-binding protein A8 S100A8
S100 calcium-binding protein A12 S100A12
Versican VCAN
Defensin, 1 DEFA1
Ficolin (collagen/fibrinogen domain containing) 1 FCN1
Triggering receptor expressed on myeloid cells 1 TREM1
Hemoglobin, 2 HBA2
MRNA full-length insert cDNA clone EUROIMAGE 85905
FBJ murine osteosarcoma viral oncogene homolog B FOSB
Fc fragment of IgA, receptor for FCAR
Hemoglobin, 1 HBA1
Cyclin-dependent kinase inhibitor 1C (p57, Kip2) CDKN1C
S100 calcium-binding protein A9 S100A9
Prokineticin 2 PROK2
Formyl peptide receptor 1 FPR1
Selectin L (lymphocyte adhesion molecule 1) SELL
Myotubularin-related protein 11 MTMR11
Proplatelet basic protein (chemokine (C-X-C motif) ligand 7) PPBP
Pre-B-cell colony-enhancing factor 1 PBEF1
Chromosome 19 open reading frame 59 C19orf59
Dendritic cells
Chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) CCL18
Chemokine (C-C motif) ligand 13 CCL13
Chemokine (C-C motif) ligand 26 CCL26
Chemokine (C-C motif) ligand 23 CCL23
Arachidonate 15-lipoxygenase ALOX15
Chemokine (C-C motif) ligand 24 CCL24
Fc fragment of IgE, low affinity II, receptor for (CD23) FCER2
CD209 molecule CD209
Chemokine (C-C motif) ligand 17 CCL17
C-type lectin superfamily 4, member G CLEC4G
Cathepsin C CTSC
Interleukin 17 receptor B IL17RB
CD1b molecule CD1B
Forkhead box Q1 FOXQ1
Chemokine (C-C motif) ligand 14 CCL14
Receptor (G protein-coupled) activity modifying protein 1 RAMP1
Wingless-type MMTV integration site family, member 5B WNT5B
Coagulation factor XIII, A1 polypeptide F13A1
Chemokine (C-C motif) ligand 13 CCL13
Purinergic receptor P2Y, G-protein coupled, 14 P2RY14
Macrophages
Chitinase 3-like 1 (cartilage glycoprotein-39) CHI3L1
Matrix metallopeptidase 9 (gelatinase B, 92-kDa gelatinase, 92-kDa type IV collagenase) MMP9
Matrix metallopeptidase 7 (matrilysin, uterine) MMP7
Chitinase 1 (chitotriosidase) CHIT1
Secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1) SPP1
ADAM-like, decysin 1 ADAMDEC1
Galanin prepropeptide GAL
Deoxyribonuclease II  DNASE2B
Cellular retinoic acid-binding protein 2 CRABP2
Transmembrane 7 superfamily member 4 TM7SF4
Similar to complement C3 precursor LOC653879
Gremlin 1, cysteine knot superfamily, homolog (Xenopus laevis) GREM1
Secretogranin V (7B2 protein) SCG5




Collagen, type XXII, 1 COL22A1
Regulator of G-protein signaling 20 RGS20
Serine dehydratase SDS
*Freshly isolated monocytes and differentiated donor-matched monocyte-derived macrophages and dendritic cells. Transcriptional profiles of
unstimulated populations were determined by oligonucleotide arrays. Data represent the top 20 constitutively expressed genes in each myeloid
population. Full expression patterns in the unstimulated cells are shown in Supplemental Table S1 available at http://ajp.amjpathol.org.
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expressed genes. After only 1 hour, 191 probesets were
differentially expressed in DCs including REL and DUSP6,
whereas 91 probesets such as IL-1RN and SOCS6 were
distinct to monocytes. Interestingly, only 32 genes were
found to be specific to P. gingivalis LPS-triggered macro-
phages. Ten transcripts were expressed both in monocytes
and macrophages whereas 61 genes/ESTs were ex-
pressed in both monocytes and DCs. Macrophages and
DCs expressed 74 transcripts exclusive of monocytes.
TLR2- and TLR4-Dependent Signaling
Whereas TLR2 signaling generates NF-B-dependent
activity, TLR4 engagement activates NF-B and the in-
terconnected transcription factor interferon regulatory
factor (IRF)3 via TRAM-TRIF adaptors26 with subsequent
triggering of type I IFN. Because ligand interactions with
TLR4, but not TLR2 trigger parallel, but separable path-
ways to influence both NF-B and IFN-linked signal trans-
duction, we examined the P. gingivalis LPS-induced tran-
scriptional profile for potential TRIF adaptor-dependent
gene induction, in addition to the evident NF-B path-
ways. Some IFN-inducible genes were concurrently up-
regulated by P. gingivalis LPS, along with IFN-1, which
may contribute to an autocrine loop impacting on IFN-
inducible genes as reported in other studies,15 including
guanylate binding protein 1, IFN-inducible (GBP1),
GBP2, and IFN-induced protein with tetratricopeptide re-
peats 2 (IFIT2) (Supplemental Table S2 available at
http://ajp.amjpathol.org). Moreover, these data suggest
that TLR4 signaling pathways were engaged by P. gingi-
valis LPS. To directly compare a dominant TLR4-medi-
ated response with the apparent TLR2/TLR4 signal in-
duced by P. gingivalis LPS, we stimulated the three
myeloid populations with E. coli LPS, a TLR4 agonist that
engages both NF-B and IRF3 pathways,27 in parallel.
The comparison of E. coli LPS (TLR4) and P. gingivalis LPS
(TLR2/TLR4) revealed enhanced IRF3 activation and in-
duction of IFN- and related genes in those cells treated
with E. coli LPS. In this regard, 12 of the top 20 signifi-
cantly differentially expressed genes are linked to IFN
pathways (Supplemental Table S3 available at http://ajp.
amjpathol.org). Consequently, our data support a prefer-
ential, although not exclusive TLR2-NF-B response for
P. gingivalis LPS, along with the TLR4 signal.
In addition to transcription induction, the intensity and
duration of TLR-induced responses are instrumental in
the sequelae after TLR-mediated initiation of an inflam-
matory response meant to protect the host against patho-
genic bacteria. In this regard, the transcriptional re-
sponses to equivalent amounts of E. coli LPS and P.
gingivalis LPS vary considerably in intensity, with many of
the P. gingivalis-induced genes (90%) expressed at a
reduced level compared with the parallel induction by E.
coli LPS (pure TLR4 agonist) that has both MyD88-de-
pendent and -independent effects on NF-B and IRF3
activation and gene expression. This was also evident at
the protein level as shown for representative pro-inflam-
matory chemokines and cytokines, CCL5/RANTES and
IL-12 (Supplemental Figure S1 available at http://ajp.
amjpathol.org).
P. gingivalis-Enhanced Expression of Chemokines
Taking a closer look at the P. gingivalis-inducible gene
profile (Supplemental Table S2 available at http://ajp.
amjpathol.org), the cell convergent response included the
early induction of genes encoding chemokines (CCL3,
CCL4, CCL5, CCL8/IL-8) at extremely high levels, particu-
larly CCL20 (MAC:MON:DC, 528:266:231 fold increase).
Rapidly enhanced expression of CXCL1, CXCL2, and
CXCL3 (Gro , , ), which engage CXCR2, is consistent
Figure 4. Corroboration of P. gingivalis LPS-
induced TNF- by microarray, RT-PCR, and pro-
tein. A: Populations of monocytes, DCs, and
macrophages were exposed to P. gingivalis LPS
(100 ng/ml) in parallel for 1 hour and the cells
processed for microarray analysis and for real-
time (RT)-PCR for TNF-. Data represent fold
increase based on P. gingivalis LPS/control (n 
3 donors). B: Cultures of monocytes, DCs, and
macrophages were treated with PBS or P. gingi-
valis LPS for 24 hours and the supernatants col-
lected and assayed for TNF- by multiplex bead
assay (mean  SEM, n  8 donors). *P  0.05.
C: Intact P. gingivalis labeled with fluorescein
isothiocyanate (100 g/ml for 30 minutes) were
added to macrophage monolayers and exam-
ined for bacterial binding at the membrane (in-
set, 5 minutes; arrows indicate membrane-as-
sociated, circle indicates internalized bacteria),
and/or uptake by the macrophages (20 min-
utes). D: Macrophage cultures were exposed to
live P. gingivalis at 10:1 or 5:1 for 1 hour and
total RNA was extracted and processed for RT-
PCR for TNF-. Data represent fold increase for
P. gingivalis LPS in two donors compared with
control. *P  0.05. Original magnifications: 63
(C, inset); 32 (C).
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with accumulation of myeloid cells. Although the magnitude
of the response relative to individual chemokines varied
between populations (Figure 5, Table 1, and Supplemental
Table S2 available at http://ajp.amjpathol.org), the P. gingi-
valis induction of a chemokine transcriptional response was
often 100-fold greater than the respective unstimulated
control populations. This enhanced gene expression was
reflected by secretion of multiple chemokines, as measured
in the 24-hour supernatants of the P. gingivalis LPS-treated
cultures (Figure 6, n  8) (representative CCL and CXCL
chemokines shown) with corresponding differences based
on cellular differentiation. Chemokine receptor expression
was not substantively altered in monocytes, DCs, or mac-
rophages, with the exception of down-regulated CCR2 in
monocytes, which may facilitate retention at the site of in-
flammation. Moreover, augmented expression of genes that
enhance adhesion and migration (CD44, CD54/ICAM1)
was seen in the stimulated cells. Enhanced tissue factor
(coagulation factor III) (MON:DC:MAC, 25:54:3) may be
geared toward promoting a local coagulation cascade to
limit microbial dissemination.
Cytokines and Co-Stimulatory Molecules
Associated with Innate/Adaptive Immunity
Cytokines with pro-inflammatory activities and linked to
engaging adaptive immunity and driving Th1 and Th17
lineage commitment, including IL-1, IL-6, IL-12, and IL-23
(Figure 5; Figure 7, A–D; and Supplemental Table S2
available at http://ajp.amjpathol.org) increased in all three
myeloid populations, albeit at quantitatively varying lev-
els. Whereas P. gingivalis LPS up-regulated expression of
the shared IL-12 and IL-23 p40 in all three populations,
the IL-23-specific p19 was typically increased to a
greater extent than IL-12p35 (Figure 7, C and D). In
addition to elevated levels of myeloid IL-1, IL-23 and IL-6,
COX2 (MON:DC:MAC, 24:65:53) has also been linked to
Th17 lineage commitment.28 Cytokine transcription was
linked to the secretion of these inflammatory mediators as
determined in 24-hour supernatants from myeloid cells
derived from eight healthy donors tested in a multiplex
bead assay. Reflecting the differential responsiveness at
the transcriptome level, protein levels for the evaluated
cytokines varied among these myeloid populations, as
shown for IL-l, IL-6, and also TNF- (Figure 3 and Figure
7, A and B). However, in keeping with the requirement for
posttranscriptional inflammasome-mediated processing
of the IL-l precursor protein,29 macrophages and DCs
secreted little active IL-l protein (Figure 7A), despite
100-fold increases in gene expression (Figure 7A and
Supplemental Table S2 available at http://ajp.amjpathol.
org). Thymic stromal lymphopoietin (TLSP), selectively
induced more than fourfold in macrophages in response
to P. gingivalis LPS, is considered a factor indirectly in-
volved in Th2 cell generation30 and only monocytes up-
regulated their expression of IL-18 (more than threefold),
a Th1-biasing cytokine. In addition to the dominant pro-
inflammatory cytokines, which suggest a bias toward
Th17 lineage polarization, several co-stimulatory mole-
cules were also up-regulated in the derivative myeloid
cell populations, including CD80, CD83, CD44, CD69,
CD58/LFA-3. The innate cell response to P. gingivalis
provides instructions for localization and lymphocyte ef-
fector cell type differentiation at the site of infection. Func-
tional links between innate and adaptive responses to
infection are forged through TLR, but interestingly, no
increased transcription of TLR (1 hour) or significant
change in cell surface expression levels of TLR2 or TLR4
(24 hours) were observed after challenge with P. gingivalis
LPS (data not shown).
Figure 5. P. gingivalis induced gene expression in monocytes, DCs, and
macrophages. A: The monocyte PgLPS/C response is plotted on the x axis
and DC PgLPS/C on the y axis both in S10 (similar to log10) scale. The green
line is threefold above the line of identity and the red line is threefold below. The
green points (44 probesets) above the green line have more than twofold
up-regulation in MON and more than threefold further up-regulation in DCs,
whereas the red points (eight probesets) below the red line are more than
twofold up-regulated in DCs and more than threefold further up-regulated in
MON as shown in Supplemental Table S2 available at http://ajp.amjpathol.org.
Only genes with 10-fold up-regulation above their respective unstimulated
control population are listed in the figure, which does not include hypothet-
ical genes, transcribed loci, and unidentified cDNA (see Table 2 for details).
B: The monocyte PgLPS/C is plotted on the x axis and macrophage PgLPS/C
on the y axis both in S10 scale. The blue line is threefold above the line of
identity and the red is threefold below. The blue points (19 probesets) above
the blue line have more than twofold up-regulation in MON and more than
threefold further up-regulation in MAC whereas the red points (16 probesets)
below the green line are more than twofold up-regulated in MAC and more
than threefold further up-regulated in MON as shown in Supplemental Table
S2 available at http://ajp.amjpathol.org. Only genes with 10-fold up-regu-
lation above their respective unstimulated control population are listed in
the figure, which does not include hypothetical genes, transcribed loci,
and unidentified cDNA (see Supplemental Table S2 available at http://
ajp.amjpathol.org for details).
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Detection of Th Lineages in Inflamed
Periodontal Tissues
Based on our in vitro data incriminating myeloid cells and
their products in periodontal pathogenesis, we further
validated our findings by assessing whether these P.
gingivalis-induced genes were reflected by potential func-
tional consequences in the inflamed tissues. The abun-
dance of myeloid cell chemokines (CCL20) and en-
hanced cytokines implicated in Th17 recruitment and
polarization (IL-1, IL-6, IL-23), were consistent with their
involvement in combating bacterial pathogens31 and re-
flected evidence for IL-17-secreting cells (Figure 1G) within
the T cell (CD3) compartment of the inflammatory lesions
(Figure 1F). IFN (Th1) cells were identified (Figure 1I),
consistent with antigen-presenting cell IL-12 gene and pro-
tein expression (Figure 7C and Supplemental Figure S1
available at http://ajp.amjpathol.org), with lesser evidence
for Th2 (IL-4) (Figure 1H) cell accumulation.
Mediators of Tissue Destruction and Bone
Resorption
Multiple factors known to impact on osteoclast formation
and function were identified in response to P. gingivalis
LPS, implicating innate immune cells from the very onset
of the response in the subsequent alterations in bone
Table 2. Relative Differences in P. gingivalis-Induced Gene Expression in Myeloid Cell Populations
Myeloid population
Gene title Gene symbol MON DC MAC
Potassium inwardly-rectifying channel, subfamily J, member 2 KCNJ2 13.7* 3.7 1.0
Immunoresponsive 1 homolog (mouse) IRG1 9.9 1.0 5.0
Interleukin 1 receptor antagonist IL1RN 9.6 1.6 1.0
Coagulation factor III (thromboplastin, tissue factor) F3 7.9 17.0 1.0
Free fatty acid receptor 2 FFAR2 7.3 2.0 1.0
Gap junction protein, 2, 26 kDa GJB2 6.4 4.9 1.0
Chemokine (C-C motif) ligand 3 CCL3 5.6 2.7 1.0
Chemokine (C-C motif) ligand 4 CCL4 5.3 1.0 1.7
Chemokine (C-X-C motif) ligand 2 CXCL2 5.2 2.1 1.0
Epiregulin EREG 4.9 1.5 1.0
Interleukin 8 IL8 1.0 14.3 7.9
Jumonji domain containing 3, histone lysine demethylase JMJD3 1.0 11.3 2.4
Dual specificity phosphatase 2 DUSP2 1.4 10.4 1.0
Arrestin domain containing 3 ARRDC3 1.0 10.1 3.2
BCL2-related protein A1 BCL2A1 1.8 9.8 1.0
Inhibin, A INHBA 1.0 9.6 1.2
Nuclear factor of  light polypeptide gene enhancer in B-cells inhibitor,  NFKBIZ 1.0 8.4 5.3
v-fos FBJ murine osteosarcoma viral oncogene homolog FOS 1.5 8.1 1.0
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) MAFF 2.4 7.5 1.0
Phorbol-12-myristate-13-acetate-induced protein 1 PMAIP1 1.0 7.5 3.3
Tumor necrosis factor, -induced protein 3 TNFAIP3 1.0 7.4 2.0
Superoxide dismutase 2, mitochondrial SOD2 1.0 7.0 2.3
Growth arrest and DNA damage-inducible,  GADD45B 1.0 7.0 4.2
Immediate early response 2 IER2 1.0 7.0 1.9
Interferon regulatory factor 1 IRF1 1.0 6.9 3.0
Tumor necrosis factor (ligand) superfamily, member 9 TNFSF9 1.0 6.8 4.0
RasGEF domain family, member 1B RASGEF1B 1.0 6.4 2.1
Chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, ) CXCL1 1.0 6.2 2.7
Dual specificity phosphatase 1 DUSP1 1.0 6.0 6.9
CD44 molecule (Indian blood group) CD44 1.0 5.9 4.8
Interleukin 1,  IL1B 1.0 5.8 1.1
Regulator of G-protein signaling 1 RGS1 1.0 5.6 1.7
DNA damage-inducible transcript 4 DDIT4 3.7 5.6 1.0
T-cell activation NFKB-like protein TA-NFKBH 1.5 5.5 1.0
Activating transcription factor 3 ATF3 1.3 5.5 1.0
Tumor necrosis factor (TNF superfamily, member 2) TNF 1.0 5.5 2.5
Interleukin 7 receptor IL7R 1.0 5.3 3.2
Mitogen-activated protein kinase kinase 3 MAP2K3 1.0 5.3 1.2
Chemokine (C-C motif) ligand 8 CCL8 1.0 5.2 1.9
Rap guanine nucleotide exchange factor (GEF) 2 RAPGEF2 1.0 5.0 2.9
Pre-B-cell colony-enhancing factor 1 PBEF1 1.0 3.7 7.1
G protein-coupled receptor 109B GPR109B 1.0 1.8 6.6
Interferon, 1, fibroblast IFNB1 1.0 4.5 6.1
Chemokine (C-C motif) ligand 5 CCL5 1.0 3.3 5.2
B-cell CLL/lymphoma 11A (zinc finger protein) BCL11A 1.0 4.7 5.0
Interferon-induced protein with tetratricopeptide repeats 2 IFIT2 1.4 1.0 4.7
*Relative changes in gene expression. The cell population expressing the lowest P. gingivalis LPS-induced fold change was set at one 1, and the
values for the other two myeloid cell populations represent their increase in gene expression relative to the population with the lowest response to P.
gingivalis LPS. Only genes with more than or equal to fivefold differential compared with the least responsive cells are shown. Hypothetical proteins,
cDNA, transcribed loci, cDNA clones, and replicate probsets are excluded from the list.
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metabolism. However, with differentiation and indepen-
dently of P. gingivalis LPS, monocyte-derived macro-
phages and DCs acquired elevated expression of MMP,
TREM2, CD44, purinergic receptor P2X (P2RX7), and
ATPase (ARP6V0D2) a component of the V-type H
ATP6i proton pump complex that secretes H from oste-
oclasts32 (Figure 3 and Supplemental Table S1 available
at http://ajp.amjpathol.org), consistent with their role as
precursors to osteoclastogenesis in the appropriate mi-
croenvironment. On P. gingivalis activation, myeloid cells
augment their repertoire of inducers/activators (TNF-,
IL-1, IL-6, COX2) at the gene and protein level (Figures
4 and 7), which not only activate existent osteoclasts,
but have the potential to drive macrophages and DCs
into the multinucleated bone resorbing osteoclast phe-
notype, likely supported by IL-17 and T-cell receptor
activator of NF-B ligand (RANKL) engagement of os-
teoclast RANK.33 Extracellular matrix-degrading pro-
teases (MMPs) are increased without an apparent corre-
sponding increase in TIMP, an imbalance supporting
exacerbation of the pathogenesis of periodontitis. P. gin-











































































































Figure 6. Chemokine protein response after ex-
posure to P. gingivalis LPS. A–C: Monocytes
(MON), macrophages (MAC), and dendritic cells
(DC) were incubated with P. gingivalis LPS for
24 hours and supernatant levels of indicated
chemokines assayed by multiplex bead assay,
demonstrating significantly elevated levels of
CCL2 (A), CCL3 (B), CXCL8 (C), and CXCL10 (D)
as part of the proteomic response to P. gingivalis
LPS, which varies quantitatively among the three
derivative populations (n  8 donors, two-tailed
Student’s t-test for correlated samples). *P 



















































































































































Figure 7. P. gingivalis LPS-induced inflamma-
tory cytokines linked to T-lineage commitment.
A and B: Monocytes (MON), macrophages
(MAC), and dendritic cells (DC) were incubated
with P. gingivalis LPS for 24 hours and superna-
tant levels of IL-l (A) and IL-6 (B) were deter-
mined by multiplex bead assay (n  8 donors,
two-tailed Student’s t-test for correlated sam-
ples). Insets: Populations of monocytes, DCs,
and macrophages were exposed to P. gingivalis
LPS (100 ng/ml) in parallel for 1 hour and the
cells processed for microarray analysis. Data
represent fold increase based on P. gingivalis
LPS/control (n  3 donors) for IL-1 (A, inset)
and IL-6 (B, inset). C: Populations of mono-
cytes, DCs, and macrophages were exposed to
P. gingivalis LPS (100 ng/ml) in parallel for 1
hour and the cells processed for microarray anal-
ysis. Data represent fold increase based on P.
gingivalis LPS/control (n  3 donors) for IL-12.
Based on gene expression levels, DCs and mac-
rophages expressed higher levels of IL-12A
(p35) than monocytes, and DCs exhibited high-
est levels of IL-12B (p40) induced by P. gingi-
valis LPS within 1 hour. D: Comparison of IL-23
p19 and p40 gene expression in the three my-
eloid cells populations revealed that whereas
DCs expressed higher levels of p40, monocytes
and macrophages expressed more p19. *P 
0.05; **P  0.01.
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(PLAU) and limited enhancement (two- to fourfold in-
crease), depending on cell type, of serine protease in-
hibitors (SERPINB 1, 2, 8, 9) (Supplemental Table S2
available at http://ajp.amjpathol.org). Osteoclasts them-
selves are TLR and P. gingivalis may affect bone loss by
directly engaging their NF-B-dependent activation path-
ways in conjunction with complex cytokine regulatory
effects related to their stage of differentiation.34
P. gingivalis Regulation of Immunosuppressive
Molecules
Of interest is the limited evidence of an emergent sup-
pressive response, with modest increases in IL-10 (five-
fold) gene expression in the more differentiated macro-
phages, and modest protein secretion in all three
populations (Figure 8A). Expression of suppressor of cy-
tokine signaling (SOCS)3, which depending on probeset,
was elevated in all three populations from 8- to 28-fold
(Figure 8B) may dampen cytokine responsiveness. IL-1R
antagonist (IL-1RN) was independently up-regulated 10-
fold in stimulated monocytes (Table 2). A loss of IFN-R1
expression was evident in all three populations subse-
quent to exposure to P. gingivalis LPS (three- to fivefold
decrease) (Supplemental Table S2 available at http://
ajp.amjpathol.org), likely minimizing IFN--mediated re-
sponsiveness, and notable was the lack of up-regulation
of TLR expression. Inhibitors of NF-B, IB, IB	, and
IB increased to varying degrees. Nonetheless, these
several potential avenues for inhibition would appear to
have limited impact in counteracting the pro-inflamma-
tory profile and/or initiating resolution. Although trans-
forming growth factor (TGF)- was not transcriptionally
elevated by P. gingivalis LPS, DCs constitutively express
higher levels of TGF- than monocytes or macrophages
(data not shown), whereas the TGF- family member,
inhibin A, was increased 17-fold in DCs, 2-fold in
macrophages, but not increased in monocytes (Supple-
mental Table S2 available at http://ajp.amjpathol.org) in
response to challenge with P. gingivalis LPS.
Another potential regulatory pathway may involve mi-
croRNA induction. The BIC transcript, a noncoding gene
containing microRNA-155(miR-155) was uniquely in-
duced by P. gingivalis LPS in all populations (MON:DC:
MAC, 23:70:13-fold) (Supplemental Table S2 available at
http://ajp.amjpathol.org). MiR-155 reportedly targets tran-
scripts coding for several proteins involved in LPS sig-
naling, Fas-associated death domain protein (FADD), IB
kinase 
, and TNFR superfamily-interacting serine-threo-
nine kinase 1(Ripk1), while concomitantly enhancing
TNF- translation.35 Through such mechanisms, BIC
could play a pivotal role in posttranscriptional modulation
of gene regulation by binding to complementary se-
quences within the 3 untranslated region of target
genes, evoking degradation or translational inhibition36
(L. Strat and S. Nares, manuscript in preparation).
A significant number of poorly characterized genes
and ESTs were also induced by P. gingivalis LPS (168 of
567, 29%). Among the top 50 most differentially ex-
pressed genes in monocytes, 12 (24%) are poorly char-
acterized, whereas in DCs 5 (10%) and in macrophages
7 (14%) have yet to be characterized. Determining the
potential role of these genes in the host response will
likely contribute to the understanding of periodontal
pathogenesis and other chronic inflammatory diseases
and reveal unexplored therapeutic targets.
Discussion
Long-lived myeloid inflammatory cells such as macro-
phages and DCs, strategically poised along portals of
entry, sample the local microenvironment in search of
PAMPs.20 On PAMP recognition, initiation of innate re-
sponses through generation of an arsenal of genes that
encode effector proteins ensues to contain and/or clear
the inciting agent, with a striking reprogramming of the
complex molecular and cellular networks within and be-
tween immune cells. As coordinators, these cells orches-
trate the transition to and the propagation of the adaptive
arm of the immune response. Aberrancies in one or more
of these processes may lead to a chronic state of inflam-
mation or infection. During gingival irritation, ulceration of
the epithelial barrier can provide a portal of entry for
pathogenic bacteria and/or their products such as those
derived from the periodontopathogen, P. gingivalis pro-
viding access to TLR immune cells.
Based on the early transcriptional profile in TLR my-
eloid cells, P. gingivalis LPS delivers a potent pro-inflam-

































































Figure 8. Induction of immunosuppressive mol-
ecules. A and B: Monocytes, DCs, and macro-
phages were exposed to P. gingivalis LPS (100
ng/ml) in parallel for 1 hour and the cells pro-
cessed for microarray analysis. Data represent
fold increase based on P. gingivalis LPS/control
(n  3 donors) for IL-10 (A) and SOCS3 (B). A,
inset: Monocytes (MON), macrophages (MAC),
and dendritic cells (DC) were incubated with P.
gingivalis LPS for 24 hours and supernatant lev-
els of IL-l0 were determined by multiplex bead
assay (n  8 donors, two-tailed Student’s t-test
for correlated samples). *P  0.05, **P  0.005.
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ulatory or anti-inflammatory gene expression. Despite
similarities in the transcriptional and proteomic profiles of
monocytes, DCs, and macrophages, we observed clear
differences in the extent and magnitude of their re-
sponses, with DCs not only displaying embellished tran-
scriptional activity, but typically secreting higher levels of
cytokines and chemokines compared with their donor-
matched monocytes and macrophages. After P. gingiva-
lis-TLR initiation of transcription, processing of tran-
scripts, their transport to cytoplasm, and translation of
mRNA with protein synthesis and secretion, all contribute
to the cellular responses to this pathogen. In this context,
the transcription factor NF-B plays a pivotal role in the
innate TLR2/TLR4 response to P. gingivalis. In addition to
NF-B, the IRF3 pathway is engaged by P. gingivalis LPS,
consistent with a TLR4 response,27 albeit to a lesser
degree than an exclusive TLR4 signal. This parallel path-
way, by coordinately regulating IFN and IFN-related
genes in the P. gingivalis LPS-stimulated myeloid popula-
tions, may in turn, regulate functions of innate cells in-
cluding CTL and NK cells, as well as the transition into an
adaptive response.
After TLR activation, IB phosphorylation by IB kinase
(IKK) and its ubiquitin-dependent degradation liberate
NF-B for nuclear translocation and regulation of target
gene transcription. Thus, a key event connecting TLR
engagement to NF-B activation is regulation of IKK ac-
tivity, controlled by opposing actions of kinases and
phosphatases37 and P. gingivalis LPS-induced protein
phosphatase regulatory inhibitor subunit 15A(PP1R15A)
may temper the ability of the cells to control this pathway
by disabling phosphatase inactivation of IKK.38 More-
over, PPP1R15A was recently linked to responsiveness to
TNF inhibitor therapy in rheumatoid arthritis.39 Among the
genes induced by P. gingivalis LPS is IB, which can
re-exert control over NF-B, along with IB 
 and partic-
ularly, IB , which binds to NF-B p50 in the nucleus and
has both negative (IL-8, TNF-) and positive (IL-6, IL-
12p40, GM-CSF, G-CSF) regulatory actions.40,41 Al-
though rapid NF-B activation is necessary for host de-
fense against microbial invasion, failure to re-exert
control with persistent NF-B activation may result in
tissue injury, and in the extreme, to organ failure, sys-
temic disease, and death.42,43
NF-B-responsive genes, including abundant chemo-
kines, were up-regulated both transcriptionally and at the
protein level, consistent with rapid mobilization and ac-
cumulation of innate and/or adaptive immune cells at the
site of P. gingivalis infection and release of cell wall com-
ponents. Most dramatic chemokine expression was a
feature of DCs, likely the first line of defense in the oral
epithelium and arbiters of mucosal immunity and toler-
ance.44 Oral lymphoid-like follicles containing CD4,
CD45RA, and CD45RO T cells in close proximity to
immobilized mature CD83 DCs and B-cells situated
within the gingival lamina10 may represent an overzeal-
ous DC-dependent T-cell response. In particular, ele-
vated levels of CCL20, observed in P. gingivalis LPS-
stimulated myeloid cells and in inflamed periodontal
tissues,45 through its ability to attract CCR6 memory T
cells, especially Th17 populations46 and immature DCs,
may continue to refuel the inflammatory response. In a
murine model of arthritis, a significant correlation existed
between IL-17 and CCL20 in diseased joints.47
Polarized with the assistance of APC, effector T cells
were previously considered to differentiate into Th1 or
Th2 phenotypes,48 but with the recent recognition of the
Th17 lineage, instrumental in antimicrobial immunity and
in inflammatory and autoimmune pathologies,49,50 there
has been renewed interest in these cells in chronic mu-
cosal lesions. P. gingivalis-activated cells not only gener-
ated IL-12, a facilitator of Th1 cells, but also IL-23, IL-1,
and IL-6, all of which support Th17 polarization, either
independently, or more likely in conjunction with TGF- in
humans,51–53 as shown in rodents.54 Delineating a role for
Th1/Th2/Th17 lineages in periodontitis is ongoing,55 but
clearly the relevant instruction molecules are abundant to
coordinate Th17, as well as Th1 lineage commitment.
Whereas some reports indicated a paucity of Th1-inducing
IL-12,56 we noted a significant increase in IL-12p35 and p40
expression and in secreted IL-12p40/p70 protein in re-
sponse to P. gingivalis LPS. Although we detected P. gingi-
valis-induced IL-10, as reported,57 levels of IL-12 were con-
sistently higher. Importantly, increased P. gingivalis-induced
expression of heterodimeric IL-23, composed of p40 and
p19, and connected to Th17 survival, were consistent with
pro-inflammatory IL-17 cells within the lesions and in-
flamed gingiva.58 IL-17 in turn accelerates innate cell re-
cruitment and activation through IL-8, CXCL1, TNF, GM-
CSF, and facilitates osteoclastogenesis.59
One of the hallmarks and most devastating aspects of
periodontal disease is the destruction to the supporting
structures of the tooth, involving osteoclastogenesis and
bone resorption. Osteoclasts are formed by fusion of
precursor cells of the monocyte/macrophage lineage,60
and CD11c DCs contribute to the pool of oste-
oclasts.44,61 Beyond the direct effects of myeloid cell
products on osteoprogenitors, Th17 cells have also been
incriminated in the dynamics of bone resorption.33,59 Po-
tentially relevant is the up-regulation of IL-7R expression
in macrophages and DCs by P. gingivalis in light of recent
evidence that IL-7 enhances osteoclastogenesis and di-
rectly sensitizes T cells to release pro-osteoclastogenic
factors including TNF- and RANKL.62 Evidence also
supports a direct TLR signaling pathway on TLR oste-
oclasts, promoting differentiation and survival, as well as
signaling of TLR osteoblasts to generate RANKL and
TNF- to further drive osteoclastogenesis.34
Our findings reveal the existence of an early aggregate
response, which may reflect a convergence profile within
an inflammatory site where all three lineage-specific pop-
ulations accumulate, co-exist, and respond to patho-
genic triggers. Their shared, unique and/or complemen-
tary transcriptional and proteomic profiles may frame the
context of the host response to P. gingivalis, contributing
to the destructive nature of periodontal inflammation.
Moreover, the microbial flora of the oral cavity provides a
source of multiple PAMPs with the potential to activate
many, if not all, TLRs, along with host-derived molecules
released by damaged cells in the chronic lesion that also
activate TLRs. The repeated pathogen-induced on-
slaughts of acute inflammatory mediators in the context of
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a chronic nonresolving lesion coalesce into a pro-inflam-
matory protease-laden destructive milieu. Beyond local
responses to oral infection with P. gingivalis, emerging
evidence supports systemic links to atherosclerosis, di-
abetes, and obesity,7,63 along with evidence that infec-
tion-mediated increases in mucosal permeability64 can
eventuate in endotoxemia-induced inflammation distally.
Continued dissection of the imbalance between inflam-
matory pathways and immunosuppressive elements may
reveal strategies to blunt chronicity and destructiveness
of pathogen-induced inflammation within the oral cavity
and also systemically, being that elimination of the incit-
ing agent(s) represents a formidable task.
Acknowledgments
We thank Richard P. Darveau, University of Washington,
Seattle, WA, for his kind gift of purified Porphyromonas
gingivalis LPS; Dr. Saravanan Periasamy (National Insti-
tute of Dental and Craniofacial Research, National Insti-
tutes of Health) for P. gingivalis; Dr. John Cisar (National
Institute of Dental and Craniofacial Research, National
Institutes of Health) for FITC-labeled P. gingivalis; Rick
Dreyfuss (Office of Research Services, National Institutes
of Health) for photomicroscopy; and Dara Stoney for
editorial assistance.
References
1. Iwasaki A, Medzhitov R: Toll-like receptor control of the adaptive
immune responses. Nat Immunol 2004, 5:987–995
2. Dostert C, Meylan E, Tschopp J: Intracellular pattern-recognition re-
ceptors. Adv Drug Deliv Rev 2008, 60:830–840
3. Madianos PN, Bobetsis YA, Kinane DF: Generation of inflammatory
stimuli: how bacteria set up inflammatory responses in the gingival.
J Clin Periodontol 2005, 32(Suppl 6):57–71
4. Gemmell E, Seymour GJ: Immunoregulatory control of Th1/Th2 cyto-
kine profiles in periodontal disease. Periodontol 2000 2004, 35:21–41
5. Haffajee AD, Socransky SS: Microbial etiological agents of destruc-
tive periodontal diseases. Periodontol 2000 1994, 5:78–111
6. Choi JI, Nakagawa T, Yamada S, Takazoe I, Okuda K: Clinical,
microbiological and immunological studies on recurrent periodontal
disease. J Clin Periodontol 1990, 17:426–434
7. Gibson III FC, Ukai T, Genco CA: Engagement of specific innate
immune signaling pathways during Porphyromonas gingivalis in-
duced chronic inflammation and atherosclerosis. Front Biosci 2008,
13:2041–2059
8. Davey M, Liu X, Ukai T, Jain V, Gudino C, Gibson III FC, Golenbock
D, Visintin A, Genco CA: Bacterial fimbriae stimulate proinflammatory
activation in the endothelium through distinct TLRs. J Immunol 2008,
180:2187–2195
9. Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR,
Howald WN, Way SS, Hajjar AM: Porphyromonas gingivalis lipo-
polysaccharide contains multiple lipid A species that functionally
interact with both toll-like receptors 2 and 4. Infect Immun 2004,
72:5041–5051
10. Jotwani R, Palucka AK, Al-Quotub M, Nouri-Shirazi M, Kim J, Bell D,
Banchereau J, Cutler CW: Mature dendritic cells infiltrate the T cell-
rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and
in vitro studies. J Immunol 2001, 167:4693–4700
11. Zhou Q, Desta T, Fenton M, Graves DT, Amar S: Cytokine profiling of
macrophages exposed to Porphyromonas gingivalis, its lipopolysac-
charide, or its FimA protein. Infect Immun 2005, 73:935–943
12. Hajishengallis G, Tapping RI, Harokopakis E, Nishiyama S, Ratti P,
Schifferle RE, Lyle EA, Triantafilou M, Triantafilou K, Yoshimura F:
Differential interactions of fimbriae and lipopolysaccharide from Por-
phyromonas gingivalis with the Toll-like receptor 2-centred pattern
recognition apparatus. Cell Microbiol 2006, 8:1557–1570
13. Hirschfeld M, Weis JJ, Toshchakov V, Salkowski CA, Cody MJ, Ward
DC, Qureshi N, Michalek SM, Vogel SN: Signaling by toll-like receptor
2 and 4 agonists results in differential gene expression in murine
macrophages. Infect Immun 2001, 69:1477–1482
14. Bainbridge BW, Darveau RP: Porphyromonas gingivalis lipopoly-
saccharide: an unusual pattern recognition receptor ligand for the
innate host defense system. Acta Odontol Scand 2001, 59:131–138
15. Zhou Q, Amar S: Identification of signaling pathways in macrophage
exposed to Porphyromonas gingivalis or to its purified cell wall com-
ponents. J Immunol 2007, 179:7777–7790
16. Parameter on chronic periodontitis with advanced loss of periodontal
support. J Periodontol 2000, 71:856–858
17. Warburton G, Nikitakis NG, Roberson P, Marinos NJ, Wu T, Sauk Jr
JJ, Ord RA, Wahl SM: Histopathological and lymphangiogenic pa-
rameters in relation to lymph node metastasis in early stage oral
squamous cell carcinoma. J Oral Maxillofac Surg 2007, 65:475–484
18. Wahl LM, Katona IM, Wilder RL, Winter CC, Haraoui B, Scher I, Wahl
SM: Isolation of human mononuclear cell subsets by counterflow
centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-,
T-lymphocyte-, and monocyte-enriched fractions by flow cytometric
analysis. Cell Immunol 1984, 85:373–383
19. Peng G, Greenwell-Wild T, Nares S, Jin W, Lei KJ, Rangel ZG,
Munson PJ, Wahl SM: Myeloid differentiation and susceptibility to
HIV-1 are linked to APOBEC3 expression. Blood 2007, 110:393–400
20. Nares S, Wahl SM: Monocytes and Macrophages. Edited by Lotze
MT, Thompson AT. London, Elsevier Science, Inc., 2005, pp 299–311
21. Aspholm M, Kalia A, Ruhl S, Schedin S, Arnqvist A, Linden S, Sjostrom
R, Gerhard M, Semino-Mora C, Dubois A, Unemo M, Danielsson D,
Teneberg S, Lee WK, Berg DE, Boren T: Helicobacter pylori adhesion to
carbohydrates. Methods Enzymol 2006, 417:293–339
22. Livak KJ, Schmittgen TD: Analysis of relative gene expression data
using real-time quantitative PCR and the 2(-delta delta C(T)) method.
Methods 2001, 25:402–408
23. Fritsche J, Muller A, Hausmann M, Rogler G, Andreesen R, Kreutz M:
Inverse regulation of the ADAM-family members, decysin and
MADDAM/ADAM19 during monocyte differentiation. Immunology
2003, 110:450–457
24. van Eijk M, Scheij SS, van Roomen CP, Speijer D, Boot RG, Aerts JM:
TLR- and NOD2-dependent regulation of human phagocyte-specific
chitotriosidase. FEBS Lett 2007, 581:5389–5395
25. Toeda K, Nakamura K, Hirohata S, Hatipoglu OF, Demircan K,
Yamawaki H, Ogawa H, Kusachi S, Shiratori Y, Ninomiya Y: Versican
is induced in infiltrating monocytes in myocardial infarction. Mol Cell
Biochem 2005, 280:47–56
26. Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R: TRAM
couples endocytosis of Toll-like receptor 4 to the induction of inter-
feron-beta. Nat Immunol 2008, 9:361–368
27. O’Neill LA: Primer: toll-like receptor signaling pathways—what do
rheumatologists need to know? Nat Clin Pract Rheumatol 2008,
4:319–327
28. Sheibanie AF, Yen JH, Khayrullina T, Emig F, Zhang M, Tuma R,
Ganea D: The proinflammatory effect of prostaglandin E2 in experimen-
tal inflammatory bowel disease is mediated through the IL-23-IL-17
axis. J Immunol 2007, 178:8138–8147
29. Church LD, Cook GP, McDermott MF: Primer: inflammasomes and
interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol
2008, 4:34–42
30. Liu YJ, Soumelis V, Watanabe N, Ito T, Wang YH, Malefyt Rde W,
Omori M, Zhou B, Ziegler SF: TSLP: an epithelial cell cytokine that
regulates T cell differentiation by conditioning dendritic cell matura-
tion. Annu Rev Immunol 2007, 25:193–219
31. Chen Z, O’Shea J: Th17 cells: a new fate for differentiating helper T
cells. Immunol Res 2008, 41:87–102
32. Lee SH, Rho J, Jeong D, Sul JY, Kim T, Kim N, Kang JS, Miyamoto T,
Suda T, Lee SK, Pignolo RJ, Koczon-Jaremko B, Lorenzo J, Choi Y:
v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast
fusion and increased bone formation. Nat Med 2006, 12:1403–1409
33. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono
Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H:
Th17 functions as an osteoclastogenic helper T cell subset that links
T cell activation and bone destruction. J Exp Med 2006, 203:
2673–2682
Myeloid Cell TLR Responses 1413
AJP April 2009, Vol. 174, No. 4
34. Bar-Shavit Z: Taking a toll on the bones: regulation of bone metabo-
lism by innate immune regulators. Autoimmunity 2008, 41:195–203
35. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B,
Fabbri M, Alder H, Liu CG, Calin GA, Croce CM: Modulation of
miR-155 and miR-125b levels following lipopolysaccharide/TNF-al-
pha stimulation and their possible roles in regulating the response to
endotoxin shock. J Immunol 2007, 179:5082–5089
36. O’Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D: Mi-
croRNA-155 is induced during the macrophage inflammatory re-
sponse. Proc Natl Acad Sci USA 2007, 104:1604–1609
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